A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors
Phase 1 Recruiting
331 enrolled
KANDLELIT-001
Phase 1 Recruiting
830 enrolled
Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
Phase 1 Recruiting
128 enrolled
Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors
Phase 1 Completed
446 enrolled 49 charts
A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas
Phase 1 Recruiting
480 enrolled
A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies
Phase 1 Recruiting
110 enrolled
A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor
Phase 1 Unknown
72 enrolled
A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors
Phase 1 Completed
243 enrolled
ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin
Phase 1 Unknown
60 enrolled
Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors
Phase 1 Terminated
41 enrolled
A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors
Phase 1 Unknown
18 enrolled
Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment
Phase 1 Completed
74 enrolled
Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors
Phase 1 Completed
25 enrolled
Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor
Phase 1 Completed
Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
46 enrolled
Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery
Phase 1 Completed
50 enrolled
Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors
Phase 1 Completed
84 enrolled
Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer
Phase 1 Unknown
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors
Phase 1 Completed
42 enrolled
Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors
Phase 1 Completed
30 enrolled
Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer
Phase 1 Terminated
30 enrolled
Oxaliplatin in Treating Children With Advanced Solid Tumors
Phase 1 Completed
26 enrolled
Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors
Phase 1 Completed
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
22 enrolled
Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer
Phase 1 Completed
Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor
Phase 1 Completed
Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction
Phase 1 Completed